GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » LT-Debt-to-Total-Asset

Halberd (Halberd) LT-Debt-to-Total-Asset : 12.50 (As of Jul. 2023)


View and export this data going back to 2009. Start your Free Trial

What is Halberd LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Halberd's long-term debt to total assests ratio for the quarter that ended in Jul. 2023 was 12.50.

Halberd's long-term debt to total assets ratio increased from Jul. 2008 (0.00) to Jul. 2023 (12.50). It may suggest that Halberd is progressively becoming more dependent on debt to grow their business.

Halberd LT-Debt-to-Total-Asset Historical Data

The historical data trend for Halberd's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Halberd LT-Debt-to-Total-Asset Chart

Halberd Annual Data
Trend Jul08 Jul22 Jul23
LT-Debt-to-Total-Asset
- 8.82 12.50

Halberd Semi-Annual Data
Jul08 Jul22 Jul23
LT-Debt-to-Total-Asset - 8.82 12.50

Halberd LT-Debt-to-Total-Asset Calculation

Halberd's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Jul. 2023 is calculated as

LT Debt to Total Assets (A: Jul. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Jul. 2023 )/Total Assets (A: Jul. 2023 )
=0.15/0.012
=12.50

Halberd's Long-Term Debt to Total Asset Ratio for the quarter that ended in Jul. 2023 is calculated as

LT Debt to Total Assets (Q: Jul. 2023 )=Long-Term Debt & Capital Lease Obligation (Q: Jul. 2023 )/Total Assets (Q: Jul. 2023 )
=0.15/0.012
=12.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Halberd  (OTCPK:HALB) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Halberd LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Halberd's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Halberd (Halberd) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Halberd Corp (OTCPK:HALB) » Definitions » LT-Debt-to-Total-Asset
Comparable Companies
TSSI SWMM SFHI VSR ETOLF ESOA ENG LYOPF BBHDF RCMT LMB CUUHF GV IBIBF LAYN EMFGF LOUIF ORN WLDN GLDD
Traded in Other Exchanges
N/A
Address
P.O. Box 25, Jackson Center, PA, USA, 16133
Website
https://www.halberdcorporation.com
Halberd Corp is a research-based biotechnology company seeking to discover and develop medical treatments for a range of diseases. The Company's extracorporeal treatment is designed to treat hard-to-cure blood-borne, neurologic and infectious diseases. The Company's patented methodology removes the appropriate bodily fluid from the patient, in a continuous fashion, like dialysis, or in a batch process, like blood sample testing.
Executives
John Christopher Maddox director, 10 percent owner, officer: President, COO, Treasurer and, other: Interim CFO 10755 VERNON, HUNTINGTON WOODS MI 48070
Mark Sven Lundquist director, 10 percent owner, officer: CEO, Secretary and Director 24655 TUDOR LANE, FRANKLIN MI 48025
Cocco Nicholas A. Jr. director 50104 N. JIMMY COURT, CHESTERFIELD MI 48047-1898
Leland Michael Thomas director 280 LASALLE PLACE, GROSSE POINTE FARMS MI 88236